Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · IEX Real-Time Price · USD
8.79
-0.96 (-9.90%)
At close: Jul 19, 2024, 4:00 PM
8.87
+0.08 (0.97%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $6.17 billion as of July 22, 2024. Its market cap has increased by 305.45% in one year.
Market Cap
6.17B
Enterprise Value
6.11B
1-Year Change
305.45%
Ranking
Category
Stock Price
$8.79
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $6.17B, an increase of 5,082.22%. That is a compound annual growth rate of 52.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 6.17B | 237.14% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 6.58B |
| Cytokinetics | 6.47B |
| HealthEquity | 6.38B |
| Grifols | 6.30B |
| Elanco Animal Health | 6.29B |
| Madrigal Pharmaceuticals | 6.12B |
| Glaukos | 6.08B |
| Acadia Healthcare Company | 6.05B |